Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) LT-Debt-to-Total-Asset : 0.00 (As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Qinghai Spring Medicinal Resources Technology Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Qinghai Spring Medicinal Resources Technology Co's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.00.

Qinghai Spring Medicinal Resources Technology Co's long-term debt to total assets ratio declined from Sep. 2023 (0.01) to Sep. 2024 (0.00). It may suggest that Qinghai Spring Medicinal Resources Technology Co is progressively becoming less dependent on debt to grow their business.

Qinghai Spring Medicinal Resources Technology Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Qinghai Spring Medicinal Resources Technology Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qinghai Spring Medicinal Resources Technology Co LT-Debt-to-Total-Asset Chart

Qinghai Spring Medicinal Resources Technology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

Qinghai Spring Medicinal Resources Technology Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.01	0.01	0.01	0.01	-

Qinghai Spring Medicinal Resources Technology Co LT-Debt-to-Total-Asset Calculation

Qinghai Spring Medicinal Resources Technology Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	9.834	/	1359.312
	=	0.01

Qinghai Spring Medicinal Resources Technology Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	2.137	/	1205.121
	=	0.00

Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Qinghai Spring Medicinal Resources Technology Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Qinghai Spring Medicinal Resources Technology Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Qinghai Spring Medicinal Resources Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qinghai Spring Medicinal Resources Technology Co Ltd (SHSE:600381) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

East New Road 1, Xining Economic and Technological Development Zone, Xining, CHN, 810007

Website

http://www.verygrass.com

Qinghai Spring Medicinal Resources Technology Co Ltd is a China-based company that principally engaged in the integrated development, utilization, production, sales, and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Company's main products are the cordyceps sinensis series products under the Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis, and raw cordyceps sinensis.

Executives

Xiao Rong	Director
Lu Yi Ping	Director

Qinghai Spring Medicinal Resources Technology Co Headlines

No Headlines